Half-year report · Q2
4360.TEDINET S100UM4U
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥9.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | −¥212m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥12m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | −¥195m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥10m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥35m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥195m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥83m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥137m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥82m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥61m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥137m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥62m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥13.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥14.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.7bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥11.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.2bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.1bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥94m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥118m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥61m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥171m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥231m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥210m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥62m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥75m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥27m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-17.05 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.3 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.7 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥301m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥673m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥673m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥26m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥330m |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥254m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥270m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥714m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥714m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥33m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥558m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 458
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | Prior1YTDDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |